Andrew Garrett discusses challenges such as patient recruitment for biotechs developing therapies for targeted populations with rare diseases.
Read ArticleRare and orphan diseases insights
ICON's Rare and Orphan Diseases team provides analysis including whitepapers, blogs and contributions to media and industry conversations relating to all aspects of rare and orphan diseases in clinical trials.
Read more